메뉴 건너뛰기
Oncologist
Volumn 10, Issue 5, 2005, Pages 301-303
Late toxicities of drugs: Bisphosphonates

(1)  Chabner, Bruce A a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

ALENDRONIC ACID; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; ZOLEDRONIC ACID;
EID: 18444376789     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.10-5-301     Document Type: Editorial
Times cited : (5)
References (12)
  • 1
    • 18444417443 scopus 로고    scopus 로고
    • Regarding "Recommendations for zoledronic acid treatment of patients with bone metastases." Letter to the Editor
    • Parles K. Regarding "Recommendations for zoledronic acid treatment of patients with bone metastases." Letter to the Editor. The Oncologist 2005;10:304-305.
    • (2005) The Oncologist , vol.10 , pp. 304-305
    • Parles, K.1
  • 2
    • 85086751743 scopus 로고    scopus 로고
    • Safety and compliance of intravenous and oral dosing regimens. Letter to the Editor
    • Jackson G. Safety and compliance of intravenous and oral dosing regimens. Letter to the Editor. The Oncologist 2005;10:313-314.
    • (2005) The Oncologist , vol.10 , pp. 313-314
    • Jackson, G.1
  • 3
    • 85084775646 scopus 로고    scopus 로고
    • Bisphosphonate safety and tolerability. Letter to the Editor
    • Body JJ. Bisphosphonate safety and tolerability. Letter to the Editor. The Oncologist 2005;10:317.
    • (2005) The Oncologist , vol.10 , pp. 317
    • Body, J.J.1
  • 4
    • 18444413286 scopus 로고    scopus 로고
    • The issue of renal safety of zoledronic acid from a nephrologist's point of view. Letter to the Editor
    • Balla J. The issue of renal safety of zoledronic acid from a nephrologist's point of view. Letter to the Editor. The Oncologist 2005;10:306-308.
    • (2005) The Oncologist , vol.10 , pp. 306-308
    • Balla, J.1
  • 5
    • 18444402682 scopus 로고    scopus 로고
    • "Safety and convenience of a 15-minute infusion of zoledronic acid": Not so safe. Letter to the Editor
    • Lugassy G. "Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe. Letter to the Editor. The Oncologist 2005;10:309-310.
    • (2005) The Oncologist , vol.10 , pp. 309-310
    • Lugassy, G.1
  • 6
    • 5444243800 scopus 로고    scopus 로고
    • Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
    • Conte P, Guarneri V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. The Oncologist 2004;9(suppl 4):28-37.
    • (2004) The Oncologist , vol.9 , Issue.4 SUPPL. , pp. 28-37
    • Conte, P.1    Guarneri, V.2
  • 7
    • 12844260206 scopus 로고    scopus 로고
    • Recommendations for zoledronic acid treatment of patients with bone metastases
    • Berenson J. Recommendations for zoledronic acid treatment of patients with bone metastases. The Oncologist 2005;10:52-62.
    • (2005) The Oncologist , vol.10 , pp. 52-62
    • Berenson, J.1
  • 8
    • 2942535834 scopus 로고    scopus 로고
    • Safety and convenience of a 15-minute infusion of zoledronic acid
    • Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid. The Oncologist 2004;9:319-329.
    • (2004) The Oncologist , vol.9 , pp. 319-329
    • Berenson, J.1    Hirschberg, R.2
  • 9
    • 0142025453 scopus 로고    scopus 로고
    • Renal failure with the use of zoledronic acid
    • Chang JT, Green L, Beitz J. Renal failure with the use of zoledronic acid. N Engl J Med 2003;349:1676-1679.
    • (2003) N Engl J Med , vol.349 , pp. 1676-1679
    • Chang, J.T.1    Green, L.2    Beitz, J.3
  • 10
    • 2142817155 scopus 로고    scopus 로고
    • Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
    • Ruggiero SL, Mehrotra B, Rosenberg TJ et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-534.
    • (2004) J Oral Maxillofac Surg , vol.62 , pp. 527-534
    • Ruggiero, S.L.1    Mehrotra, B.2    Rosenberg, T.J.3
  • 11
    • 0037112368 scopus 로고    scopus 로고
    • Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats
    • Fournier P, Boissier S, Filleur S. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002;62:6538-6544.
    • (2002) Cancer Res , vol.62 , pp. 6538-6544
    • Fournier, P.1    Boissier, S.2    Filleur, S.3
  • 12
    • 14944368720 scopus 로고    scopus 로고
    • COX-2 Inhibitors - Lessons in drug safety
    • Epub ahead of print
    • Psaty BM, Furberg CD. COX-2 Inhibitors - Lessons in drug safety. N Engl J Med 2005 [Epub ahead of print].
    • (2005) N Engl J Med
    • Psaty, B.M.1    Furberg, C.D.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.